Ellipses Pharma Prepares for London Stock Exchange Listing

Cancer drug venture Ellipses Pharma is preparing to list on the London Stock Exchange at a valuation between £450m and £500m through a reverse takeover of cash shell Wolfram Resources, City AM reported.

The clinical-stage oncology venture, founded by British biotech entrepreneur Sir Chris Evans, is targeting a listing as soon as February. The deal involves reversing into Wolfram Resources, a cash shell previously focused on precious metals exploration in central Asia.

Reverse takeovers provide a fast-track route to public markets compared to a standard initial public offering. Private bank Berenberg has been appointed to manage the deal, while Ellipses prepares to appoint non-executive directors to its board.

Evans had previously weighed up alternative listing venues. He considered the Nasdaq for the firm’s home, while Hong Kong was floated as a possible venue in 2025.

The venture’s single largest investor is Abu Dhabi’s sovereign wealth fund, which holds a 45 per cent stake. Waleed al-Mokarrab al-Muhairi, deputy chief executive of the Mubadala Investment Company, sat on the board until March 2025.

Other investors include Redrow founder Steve Morgan and Sir Tom Hunter’s West Coast Capital. The company has also attracted celebrity backers, including comedian Jimmy Carr and Andrew Lloyd Webber.

Ellipses employs around 40 people, primarily from big pharma companies, and has invested roughly £185m in its drug pipeline. The firm launched a clinical trial programme in the UAE in December 2024.

Royal Bank of Canada and M&A advisory firm Pharma Ventures have been lined up to advise on potential out-license deals with major pharmaceutical companies. A formal announcement regarding the listing could be made as soon as this week.

Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

ULA’s Vulcan Rocket Fails in Inaugural Launch for Amazon

Maria Georgas, Shane Parton, and Chelsea Lazkani Win The Mob Season 1